Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00901407 · ClinicalTrials.gov registry record · NA
Lamotrigine Augmentation in Resistant Depression
A NA study, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
NCT00901407 is a NA study that has completed, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 138 participants.
The verdict
NCT00901407, a NA study, has completed, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
Study Summary
This study is intended to evaluate the efficacy and safety of lamotrigine as an antidepressant augmentation agent in a sample of individuals with major depression and a history of both prior non-response and prospective failure to respond to at least one adequate trial of an antidepressant (for a total of two failed trials).
Interventions
- DRUG placebo
- DRUG paroxetine
- DRUG lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2003-12 |
| Est. Completion | 2007-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00901407
The ClinicalTrials.gov registry entry for NCT00901407 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00901407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00901407 about?
NCT00901407 is a clinical study titled "Lamotrigine Augmentation in Resistant Depression". This study is intended to evaluate the efficacy and safety of lamotrigine as an antidepressant augmentation agent in a sample of individuals with major depression and a history of both prior non-response and prospective failure to respond to at least one adequate trial of an antidepressant (for a to...
What is the current status of trial NCT00901407?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2003-12. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00901407?
The interventions under investigation include: placebo (DRUG), paroxetine (DRUG), lamotrigine (DRUG).
Who is sponsoring clinical trial NCT00901407?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.